CXCL9 and lung cancer: We also demonstrated that CXCL9 increased in the serum of patients with lung cancer (n = 5, 1491 ± 663 pg/mL) compared to that in healthy volunteers (n = 605 ± 381 pg/mL) (p = 0.083, Figure 4J).